76 related articles for article (PubMed ID: 20357501)
1. Significance of antinuclear antibodies and rheumatoid factor in patients with advanced peripheral arterial disease.
Qadan LR; Ahmed AA; Abdel-Jalil S; Al-Bader MA
Med Princ Pract; 2010; 19(3):192-5. PubMed ID: 20357501
[TBL] [Abstract][Full Text] [Related]
2. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
3. IgA rheumatoid factor in primary Sjogren's syndrome.
Peen E; Mellbye OJ; Haga HJ
Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
[TBL] [Abstract][Full Text] [Related]
4. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
5. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
Gulez N; Karaca NE; Aksu G; Kutukculer N
Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
[TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies and peripheral arterial occlusive disease].
Kroeger K; Kreuzfelder E
Herz; 2004 Feb; 29(1):26-31. PubMed ID: 14968339
[TBL] [Abstract][Full Text] [Related]
7. [Significance of citrullinated collagen type II and its antibodies in rheumatoid arthritis].
Tian X; Bi LQ; Li ZG
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(33):2334-8. PubMed ID: 17156630
[TBL] [Abstract][Full Text] [Related]
8. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
[TBL] [Abstract][Full Text] [Related]
10. Failure to demonstrate any interaction between polyclonal rheumatoid factors and IgG antinuclear antibodies or other IgG autoantibodies.
Scott-Morgan L; Lloyd RS
Clin Exp Immunol; 1980 Aug; 41(2):297-302. PubMed ID: 6160005
[TBL] [Abstract][Full Text] [Related]
11. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease.
Vu JD; Vu JB; Pio JR; Malik S; Franklin SS; Chen RS; Wong ND
Am J Cardiol; 2005 Sep; 96(5):655-8. PubMed ID: 16125489
[TBL] [Abstract][Full Text] [Related]
12. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
13. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity.
Kessel A; Elias G; Pavlotzky E; Zuckerman E; Rosner I; Toubi E
Hum Immunol; 2007 Oct; 68(10):844-8. PubMed ID: 17961773
[TBL] [Abstract][Full Text] [Related]
14. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
15. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
16. Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children.
Kasapçopur O; Ozbakir F; Arisoy N; Ingöl H; Yazici H; Ozdoğan H
Turk J Pediatr; 1999; 41(1):67-71. PubMed ID: 10770678
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease.
Franck M; Staub HL; Petracco JB; Norman GL; Lassen AJ; Schiavo N; Borges RB; von Mühlen CA
Angiology; 2007; 58(3):295-302. PubMed ID: 17626983
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
De Rycke L; Verhelst X; Kruithof E; Van den Bosch F; Hoffman IE; Veys EM; De Keyser F
Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
20. Effects of rheumatoid factor, antinuclear antibodies and plasma reagin on the serologic assay for Lyme disease.
Lovece S; Stern R; Kagen LJ
J Rheumatol; 1991 Dec; 18(12):1813-8. PubMed ID: 1795317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
